Author:
Xiang Qiu,Tang Juan,Luo Qin,Xue Jinfeng,Tao Yexing,Jiang Honghui,Tian Jing,Fan Caiwen
Funder
The National Natural Science Foundation of China
Guangxi Natural Science Foundation
Research Fund of the Guangxi Zhuang Autonomous Region Education Department
Open Funds of the Guangxi Key Laboratory of Tumor Immunology and Micro environmental Regulation
Subject
Pharmacology,General Medicine
Reference47 articles.
1. Breast cancer statistics and markers;Donepudi;J. Cancer Res. Ther.,2014
2. Challenges in the management of advanced, ER-positive, HER2-negative breast cancer;Hart;Nat. Rev. Clin. Oncol.,2015
3. Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial;Wu;Trials,2017
4. Anti-cancer, anti-diabetic and other pharmacologic and biological activities of penta-galloyl-glucose;Zhang;Pharm. Res.,2009
5. 1,2,3,4,6-Penta-O-galloyl-β-D-glucose suppresses colon cancer through induction of tumor suppressor;Kawk;Bioorg. Med. Chem. Lett.,2018
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pentagalloyl Glucose: A Review of Anticancer Properties, Molecular Targets, Mechanisms of Action, Pharmacokinetics, and Safety Profile;Molecules;2023-06-19
2. Osteoblast Biospecific Extraction Conjugated with HPLC Analysis for Screening Bone Regeneration Active Components from Moutan Cortex;Combinatorial Chemistry & High Throughput Screening;2023-06-07
3. Penta-O-galloyl-β-d-glucose inhibits the formation of advanced glycation end-products (AGEs): A mechanistic investigation;International Journal of Biological Macromolecules;2023-05
4. In vitro anti-hepatocellular carcinogenesis of 1,2,3,4,6-Penta-O-galloyl-β-D-glucose;Food & Nutrition Research;2023-03-27
5. Network pharmacology and molecular docking identify mechanisms of medicinal plant-derived 1,2,3,4,6-penta-O-galloyl-beta-D-glucose treating gastric cancer;BIOCELL;2023